Guidant drama keeps building Stock sales by Dollens, others may stoke lawsuits. Analysts say firm will be OK if sale to Johnson & Johnson unravels.
Please enable JavaScript to view this content.
Guidant drama keeps building Stock sales by Dollens, others may stoke lawsuits. Analysts say firm will be OK if sale to Johnson & Johnson unravels.
Please enable JavaScript to view this content.
Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.